Literature DB >> 3131951

An analysis of cellular proliferation, and synthesis of lymphokines and specific antibody in vitro by leucocytes from immunized cattle.

D L Emery1, J H Dufty, P R Wood.   

Abstract

The relationships between the production of lymphokines, cellular proliferation and antibody synthesis by immune bovine PBL in vitro was examined to identify the cellular reactions responsible for differences in the titres of serum antibodies in calves from selected sire lines and MHC Class I phenotypes. Leucocytes from 22 calves immunized with ovalbumin and DNP-BSA proliferated specifically in vitro in the presence of 1-10 micrograms/ml ovalbumin 7-28 days after the second vaccination. Significant correlations between the production of IL-2, IFN-gamma and maximum proliferation were observed for the total group. The quantity of specific antibody produced when PBL were incubated alone or with 10(-1)-10(-2) micrograms/ml ovalbumin was also correlated significantly with the maximum proliferation and the serum antibody titre between 7 and 14 days. Anti-ovalbumin IgG was also synthesized in MLRs where the quantity of antibody was significantly correlated with the magnitude of proliferation. The responses in vitro to DNP-BSA were too low to provide meaningful comparisons. The results indicate that at intervals during the period of increasing serum titres, events in the bovine antibody response in vivo can be replicated in vitro. In addition, assays for proliferation, IL-2 or gamma-IFN, or specific antibody can be used to assess the magnitude of the immune response in vivo in experimental groups of cattle. Significant sire line differences in the serological responses to ovalbumin were observed but DNP-BSA was a poorer antigen and differences in the responses to this antigen were not significant. However, the sire line differences in vivo were not reflected in vitro in proliferative and lymphokine assays; only the production of antibody in vitro was significantly correlated with the in vivo serum titre.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131951     DOI: 10.1016/0165-2427(88)90037-2

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Minimum infective dose of Mycobacterium bovis in cattle.

Authors:  Gillian S Dean; Shelley G Rhodes; Michael Coad; Adam O Whelan; Paul J Cockle; Derek J Clifford; R Glyn Hewinson; H Martin Vordermeier
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle.

Authors:  H M Vordermeier; P C Cockle; A Whelan; S Rhodes; N Palmer; D Bakker; R G Hewinson
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

3.  Modulation of immune responses to Mycobacterium bovis in cattle depleted of WC1(+) gamma delta T cells.

Authors:  Hilary E Kennedy; Michael D Welsh; David G Bryson; Joseph P Cassidy; Fiona I Forster; Christopher J Howard; Robert A Collins; John M Pollock
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

4.  Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis.

Authors:  S G Rhodes; N Palmer; S P Graham; A E Bianco; R G Hewinson; H M Vordermeier
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

5.  Bovine tuberculosis: immune responses in the peripheral blood and at the site of active disease.

Authors:  S G Rhodes; B M Buddle; R G Hewinson; H M Vordermeier
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

6.  Antigen specificity in experimental bovine tuberculosis.

Authors:  S G Rhodes; D Gavier-Widen; B M Buddle; A O Whelan; M Singh; R G Hewinson; H M Vordermeier
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

7.  Immune responses induced in cattle by virulent and attenuated Mycobacterium bovis strains: correlation of delayed-type hypersensitivity with ability of strains to grow in macrophages.

Authors:  D N Wedlock; F E Aldwell; D M Collins; G W de Lisle; T Wilson; B M Buddle
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.